company background image
GETI

GetingeOM:GETI B Stock Report

Last Price

kr330.50

Market Cap

kr90.0b

7D

-6.9%

1Y

71.4%

Updated

18 Jan, 2022

Data

Company Financials +
GETI B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance3/6
Financial Health5/6
Dividends2/6

GETI B Stock Overview

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.

Getinge Competitors

Elekta

OM:EKTA B

kr38.3b

Johnson & Johnson

NYSE:JNJ

US$439.9b

Roche Holding

SWX:ROG

CHF295.2b

Thermo Fisher Scientific

NYSE:TMO

US$232.5b

Price History & Performance

Summary of all time highs, changes and price drops for Getinge
Historical stock prices
Current Share Pricekr330.50
52 Week Highkr431.60
52 Week Lowkr191.85
Beta0.44
1 Month Change-11.70%
3 Month Change-16.81%
1 Year Change71.42%
3 Year Change301.97%
5 Year Change115.45%
Change since IPO844.29%

Recent News & Updates

Jan 09
Calculating The Fair Value Of Getinge AB (STO:GETI B)

Calculating The Fair Value Of Getinge AB (STO:GETI B)

Does the January share price for Getinge AB ( STO:GETI B ) reflect what it's really worth? Today, we will estimate the...

Dec 27
Getinge (STO:GETI B) Has A Rock Solid Balance Sheet

Getinge (STO:GETI B) Has A Rock Solid Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Dec 01
Should You Be Adding Getinge (STO:GETI B) To Your Watchlist Today?

Should You Be Adding Getinge (STO:GETI B) To Your Watchlist Today?

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

GETI BSE Medical EquipmentSE Market
7D-6.9%-7.2%-3.8%
1Y71.4%5.9%17.8%

Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned 7.9% over the past year.

Return vs Market: GETI B exceeded the Swedish Market which returned 20.1% over the past year.

Price Volatility

Is GETI B's price volatile compared to industry and market?
GETI B volatility
GETI B Average Weekly Movement5.0%
Medical Equipment Industry Average Movement7.9%
Market Average Movement6.8%
10% most volatile stocks in SE Market11.7%
10% least volatile stocks in SE Market3.8%

Stable Share Price: GETI B is less volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: GETI B's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190410,667Mattias Perjoshttps://www.getinge.com

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, and logistic automation solutions; practice-oriented monitoring systems and disposables, vascular and cardiothoracic surgery solutions, anesthesia machines, beating heart surgery solutions, ceiling supply units, connected solutions, and indicators, as well as washer-disinfectors, consumables, and IT-solutions.

Getinge Fundamentals Summary

How do Getinge's earnings and revenue compare to its market cap?
GETI B fundamental statistics
Market Capkr90.02b
Earnings (TTM)kr3.29b
Revenue (TTM)kr27.90b

27.3x

P/E Ratio

3.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GETI B income statement (TTM)
Revenuekr27.90b
Cost of Revenuekr13.97b
Gross Profitkr13.93b
Expenseskr10.64b
Earningskr3.29b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Jan 28, 2022

Earnings per share (EPS)12.09
Gross Margin49.94%
Net Profit Margin11.80%
Debt/Equity Ratio18.8%

How did GETI B perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

25%

Payout Ratio

Valuation

Is Getinge undervalued compared to its fair value and its price relative to the market?

27.34x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: GETI B (SEK330.5) is trading above our estimate of fair value (SEK261.03)

Significantly Below Fair Value: GETI B is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: GETI B is good value based on its PE Ratio (27.3x) compared to the Swedish Medical Equipment industry average (55.8x).

PE vs Market: GETI B is poor value based on its PE Ratio (27.3x) compared to the Swedish market (22.7x).


Price to Earnings Growth Ratio

PEG Ratio: GETI B is poor value based on its PEG Ratio (6.1x)


Price to Book Ratio

PB vs Industry: GETI B is good value based on its PB Ratio (3.8x) compared to the SE Medical Equipment industry average (4.8x).


Future Growth

How is Getinge forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

4.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GETI B's forecast earnings growth (4.5% per year) is above the savings rate (0.3%).

Earnings vs Market: GETI B's earnings (4.5% per year) are forecast to grow faster than the Swedish market (4.2% per year).

High Growth Earnings: GETI B's earnings are forecast to grow, but not significantly.

Revenue vs Market: GETI B's revenue (5.4% per year) is forecast to grow faster than the Swedish market (5.1% per year).

High Growth Revenue: GETI B's revenue (5.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GETI B's Return on Equity is forecast to be low in 3 years time (11.3%).


Past Performance

How has Getinge performed over the past 5 years?

41.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GETI B has high quality earnings.

Growing Profit Margin: GETI B's current net profit margins (11.8%) are higher than last year (10.3%).


Past Earnings Growth Analysis

Earnings Trend: GETI B's earnings have grown significantly by 41% per year over the past 5 years.

Accelerating Growth: GETI B's earnings growth over the past year (7.9%) is below its 5-year average (41% per year).

Earnings vs Industry: GETI B earnings growth over the past year (7.9%) underperformed the Medical Equipment industry 44.6%.


Return on Equity

High ROE: GETI B's Return on Equity (13.9%) is considered low.


Financial Health

How is Getinge's financial position?


Financial Position Analysis

Short Term Liabilities: GETI B's short term assets (SEK15.2B) exceed its short term liabilities (SEK1.6B).

Long Term Liabilities: GETI B's short term assets (SEK15.2B) do not cover its long term liabilities (SEK17.8B).


Debt to Equity History and Analysis

Debt Level: GETI B has more cash than its total debt.

Reducing Debt: GETI B's debt to equity ratio has reduced from 113.8% to 18.8% over the past 5 years.

Debt Coverage: GETI B's debt is well covered by operating cash flow (166.8%).

Interest Coverage: GETI B's interest payments on its debt are well covered by EBIT (31.5x coverage).


Balance Sheet


Dividend

What is Getinge current dividend yield, its reliability and sustainability?

0.91%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GETI B's dividend (0.91%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (0.96%).

High Dividend: GETI B's dividend (0.91%) is low compared to the top 25% of dividend payers in the Swedish market (3.32%).


Stability and Growth of Payments

Stable Dividend: GETI B's dividend payments have been volatile in the past 10 years.

Growing Dividend: GETI B's dividend payments have fallen over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (24.8%), GETI B's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GETI B's dividends in 3 years are forecast to be well covered by earnings (24.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average management tenure


CEO

Mattias Perjos (49 yo)

4.83yrs

Tenure

kr66,706,000

Compensation

Mr. Mattias Perjos has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serves as Chief Executive Officer at FlexLink Systems, Inc. Mr. Perjos has been the Dire...


CEO Compensation Analysis

Compensation vs Market: Mattias's total compensation ($USD7.31M) is above average for companies of similar size in the Swedish market ($USD2.31M).

Compensation vs Earnings: Mattias's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: GETI B's management team is considered experienced (4.6 years average tenure).


Board Members

Experienced Board: GETI B's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: GETI B insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Getinge AB's employee growth, exchange listings and data sources


Key Information

  • Name: Getinge AB
  • Ticker: GETI B
  • Exchange: OM
  • Founded: 1904
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: kr90.018b
  • Shares outstanding: 272.37m
  • Website: https://www.getinge.com

Number of Employees


Location

  • Getinge AB
  • Lindholmspiren 7A
  • Gothenburg
  • Västra Götaland County
  • 417 56
  • Sweden

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/18 21:08
End of Day Share Price2022/01/18 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.